Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled Trial

BACKGROUND AND OBJECTIVE: Oral tramadol, an atypical opioid approved in the United States (US) since 1995 and a Schedule IV controlled substance, has less abuse liability compared to Schedule II conventional opioids. Intravenous (IV) tramadol is not available in the US, but has the potential to fill...

Descripción completa

Detalles Bibliográficos
Autores principales: Minkowitz, Harold, Salazar, Hernan, Leiman, David, Solanki, Daneshvari, Lu, Lucy, Reines, Scott, Ryan, Michael, Harnett, Mark, Singla, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419412/
https://www.ncbi.nlm.nih.gov/pubmed/32409981
http://dx.doi.org/10.1007/s40268-020-00309-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419412/
https://www.ncbi.nlm.nih.gov/pubmed/32409981
http://dx.doi.org/10.1007/s40268-020-00309-0

Ejemplares similares